ArticleCancer letters2014

Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283.

William Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.